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Abstract
Background: In South Asia, it is estimated that 80% of patients choose to attend a private facility for their
healthcare needs. Although patients generally believe that the private-sector provides high quality services, private
diagnostic laboratories are largely unregulated and little is known about the accuracy of results provided. This study
assesses the accuracy of sputum smear microscopy for pulmonary tuberculosis diagnosis in private laboratories
operating in Karachi, Pakistan. A novel evaluation methodology was designed in which patient-actors submitted
sputum specimens spiked with cultured Mycobacterium tuberculosis (Mtb) for testing such that laboratories were
not aware that they were being assessed.
Methods: Smear-negative sputum specimens from Indus Hospital TB Program patients were collected and
combined with an attenuated, cultured Mtb strain to create Mtb-spiked samples; for negative standards, no Mtb
was added to the smear-negative sputum specimens. Seven of the largest private laboratories across Karachi were
chosen for evaluation and were sent six Mtb-spiked and one Mtb-negative sputum specimens. Patient-actors
pretending to be laboratory customers submitted these specimens to each laboratory for testing over a three day
period.
Results: Only three laboratories accurately classified all the Mtb-spiked specimens which were submitted. A further
three misclassified all the Mtb-spiked specimens as smear-negative, thus providing the ‘patients’ with false negative
results.
Conclusions: TB sputum smear microscopy services are highly variable across private laboratories and are often of
extremely poor quality. Engagement, capacity building and rigorous monitoring of standards at private laboratories
are of vital importance for the control of TB. Our findings, while specific for TB diagnostic tests, could be
symptomatic of other tests performed in private laboratories and warrant further investigation.
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Background
Despite improvements in the functioning of
government-run tuberculosis (TB) control programs
over the past two decades, case detection still falls short
of the Millennium Development Goal target of diagnos-
ing 70% of new TB cases. It is estimated that 35% of all
incident TB cases, which amounts to over 3 million
infected individuals, were not detected by TB control
programs in 2010 [1]. It is now widely recognized that
strengthening public-sector TB diagnostic and treatment
services alone is not enough to reduce transmission of
TB. Engaging with private health facilities, and under-
standing the strengths and weaknesses of the services
they provide to TB patients, is crucial to improving case
detection and treatment.
South Asia in particular has experienced a huge ex-
pansion in the private healthcare sector over the past
two decades, resulting in the region having the highest
rate of private-sector healthcare utilization globally. An
estimated 80% of all patients in the region attend private
facilities for their healthcare needs, including TB diag-
nostic and treatment services [2,3]. Private healthcare fa-
cilities are utilized by all groups of society, including the
poorest, owing to better privacy, accessible locations,* Correspondence: andrew.codlin@irdresearch.org1Interactive Research and Development (IRD), Suite 508, Ibrahim Trade
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more convenient opening hours and perceived higher-
quality care compared with government-run facilities.
Pakistan, which has the fifth-highest TB burden glo-
bally, is a prime example of a country with an active pri-
vate health sector [1]. Reports indicate that for each
patient visit to a public-sector healthcare facility in Paki-
stan, there are more than three visits to a private practi-
tioner [2]. Private allopathic health facilities are found
mainly in cities, and comprise small clinics run by
trained or untrained general practitioners, large hospi-
tals, diagnostic laboratories and pharmacies. All of these
private facilities are visited by TB suspects and numer-
ous public private mix (PPM) programs have success-
fully increased TB case detection and notification
through their engagement [4-6]. However, the scalability
and replicability of these programs have yet to be
demonstrated. Currently, less than 30 private-sector fa-
cilities based in Karachi, a city of over 20 million, are
reporting TB cases to the Provincial TB Program, Sindh.
Despite the size of the private healthcare sector in
South Asia, little is known about the quality of services
offered by private establishments. Reports indicate that
general practitioners often prescribe inappropriate drug
regimens to treat TB [7,8] and that TB diagnostic tests
at private laboratories are substandard [9]. In Pakistan,
as in most low- and middle-income countries, sputum
smear-microscopy is the most common test used to con-
firm TB infection due to its limited cost and equipment
requirements. However, the test is heavily dependent
on the microscopy technician and involves several
steps, all of which must be performed correctly, to ob-
tain reliable results [9]. To monitor and improve the
quality of smear-microscopy at diagnostic centres, the
National Tuberculosis Control Programme (NTP) of
Pakistan runs an External Quality Assurance (EQA) pro-
gram for all diagnostic centres that collaborate with
them on case notification. The EQA program includes
site inspections of laboratory facilities, panel testing, and
collection and blinded rereads of saved slides to check
that initial slide reading and reporting was accurate.
Currently, most private sector TB diagnostic facilities in
Pakistan fall outside the scope of these EQA efforts, and
many do not agree to participate in quality assurance
procedures.
The objective of this study was to assess the accuracy
of sputum smear microcopy services in private labora-
tories in Karachi, Pakistan. As all currently accepted
EQA methods require the knowledge and consent of the
facility being evaluated, a novel methodology was
designed in which patient-actors submitted sputum spe-
cimens spiked with Mycobacterium tuberculosis (Mtb) to
private laboratories, allowing for laboratory reported
results to be compared against the known smear-
microscopy results.
Methods
Specimen collection and preparation
The sputum specimens used for this study were col-
lected from TB suspects at the Indus Hospital TB Con-
trol Program clinic following standard hospital
procedures. Though it was recently established and is
entirely funded by grants and donations, the Indus Hos-
pital TB Control Program is the highest volume TB
treatment center in Karachi. The hospital currently
serves as a reference lab for the programmatic manage-
ment of drug-resistant tuberculosis for the province of
Sindh.
Sputum specimens were first processed using standard
Ziehl-Neelsen (ZN) staining and sputum smear micros-
copy techniques to determine their smear status. To
make Mtb-spiked sputum specimens, smear-negative
sputum specimens were inoculated with cultured Mtb as
follows. Fresh cultures of the attenuated Mtb strain
H37Rv (ATCC #27294) were grown on Löwenstein-
Jensen (LJ) slants and then transferred into sterile 7H9
broth. Glass beads (1-2mm) were added and the suspen-
sion was vortexed to make a homogenous bacterial sus-
pension, with an absorbance greater than 1 McFarland.
The suspension was allowed to stand undisturbed for 20
minutes so clumped Mtb could fall out of solution. The
supernatant was then transferred to a new test tube.
The suspension in the second test tube was allowed
to stand undisturbed for a further 15 minutes, before
the supernatant was transferred to a third test tube.
The suspension turbidity was then adjusted to
0.5 McFarland by adding additional 7H9 broth. 100μL
of the 0.5 McFarland Mtb suspension was added to
5mL of smear-negative sputum and the suspension
was vortexed to create a spiked sputum specimen
with a 1+ designation. For Mtb negative standards,
7H9 broth containing no cultured Mtb was added to
the sputum specimen.
In total, 56 Mtb-spiked sputum specimens were made:
6 smear-positive and 1 smear-negative specimens for
each laboratory targeted in this evaluation. ZN staining
and sputum smear microscopy was performed by the
Indus Hospital laboratory manager on these specimens
to confirm their classification as smear-positive or
-negative before they were transported to any private
laboratories. For safe transport, Mtb-spiked sputum
specimens were loaded by the Indus Hospital laboratory
into sterile, twist-cap containers and packed inside a
sealed cooler box.
Private lab identification and specimen submission
Seven high-volume private laboratories were chosen for
inclusion in this evaluation. Four laboratories are part of
an extensive network system where biological specimens
are sent to a central branch for testing from satellite
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sites located throughout the city. The remaining three
laboratories are standalone facilities. Together, these
seven labs represent the majority of private laboratory
services in Karachi.
Three patient-actors were recruited, after taking
informed consent to participate in the study. They
were instructed on biosafety measures to avoid acci-
dental infection, including that they were not to open
any of the twist-cap containers and to return to the
hospital without touching any contaminated material
should any of the containers leak during transport. A
cell phone was provided to the patient-actors to moni-
tor their progress and trouble shoot any issues that
arose once they left the hospital. The patient-actors
visited each laboratory and posed as customers, with
assumed names, ages and general practitioner diagnos-
tic test prescriptions. They paid for sputum smear mi-
croscopy tests in the same way as all other laboratory
customers and submitted the spiked sputum specimens
over a three day period, such that each lab under
evaluation received 7 specimens. Additionally, 7 speci-
mens were sent to the Indus Hospital laboratory for
blinded testing. De-identified laboratory IDs were
assigned to each private laboratory which reflect the
relative cost of sputum smear microscopy among the
evaluated laboratories, with 1 being the most and 7
the least expensive.
Test results from the private laboratories were picked
up by the patient-actor the day after each specimen was
submitted. Results were entered into an Access database
and frequencies of correct classification were calculated
using SAS 9.0 (Cary, North Carolina).
This study acquired ethical approval from the Office
for Human Research Protections (OHRP) registered in-
stitutional review board of Indus Hospital (no.
IRD_IRB_2011_9_003). All sputum specimens were
strictly de-identified and were obtained from the Indus
Hospital laboratory after routine test results had
reported back to clinicians and patients and the speci-
mens were flagged for disposal.
Results
Table 1 indicates the frequency and percent of correct
sputum smear classification at each laboratory. Only two
of seven private laboratories correctly classified all the
specimens which were submitted, with four laboratories
correctly classifying less than half of submitted speci-
mens. For several laboratories, only the Mtb negative
specimens were correctly classified. In light of this find-
ing, the percentage of correctly identified Mtb-spiked
and Mtb-negative specimens (respectively representing
the sensitivity and specificity of sputum smear micros-
copy at each laboratory) are shown. Three laboratories
correctly classified all of the Mtb-spiked specimens,
while three others incorrectly classified all the Mtb-
spiked specimens as smear-negative. Laboratory 6 was
the only facility to incorrectly classify an Mtb-negative
specimen as smear-positive. Indus Hospital laboratory
technicians did not know that they were under evalu-
ation or that the specimens were laboratory-made, yet
they correctly classified all submitted specimens.
Discussion
To our knowledge, this is the first study to assess the
quality of TB diagnostic services at private laboratories
by sending Mtb-spiked sputum specimens for testing,
with the facility under review being unaware of the
evaluation. Our results show that sputum smear micros-
copy services in the seven largest private laboratories in
Karachi are variable and often of extremely poor quality.
Four out of the seven laboratories assessed provided in-
correct results to the patient-actors, stating that their
sputum did not contain TB bacteria, when in fact, it was
an Mtb-spiked specimen. Further, three of the seven la-
boratories provided false negative results for all six Mtb-
spiked specimens that were submitted for testing. The
finding that several laboratories are consistently failing
to identify bacteria in sputum specimens known to con-
tain Mtb is surprising and raises important concerns.
It is likely that a large number of infectious TB cases
are going undiagnosed at these laboratories because






All Specimens, n (%) Smear-Positive Specimens, n (%) Smear-Negative Specimens, n (%)
1 Network 3 (42.9) 2 (33.3) 1 (100)
2 Network 7 (100) 6 (100) 1 (100)
3 Standalone 1 (14.3) 0 (0) 1 (100)
4 Standalone 1 (14.3) 0 (0) 1 (100)
5 Network 1 (14.3) 0 (0) 1 (100)
6 Standalone 6 (85.7) 6 (100) 0 (0)
7 Network 7 (100) 6 (100) 1 (100)
Indus Hospital N/A 7 (100) 6 (100) 1 (100)
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patients and their physicians are receiving results falsely
stating that submitted sputum specimens are free of
Mtb. Although physicians likely ordered a sputum smear
microscopy test based on clinical and/or radiological
suggestions of TB, upon receiving false negative results,
they may delay initiating TB treatment or unduly rule
out TB as the patient’s diagnosis. As TB patients with
bacteria in their sputum are both more infectious and
more likely to have a poor prognosis compared with
smear-negative TB patients, the receipt of inaccurate test
results from a diagnostic laboratory is likely to have an
adverse impact on the patient and his/her contacts.
Additionally, this study highlights the need for rigor-
ous assessment and regulation of TB diagnostic services,
and potentially other diagnostic services, offered in the
private sector. Test results from private laboratories are
generally perceived by both patients and physicians to
be more reliable than those from over-burdened, public
facilities; often a (correct) smear-positive diagnosis from
a government centre will be disregarded if a negative re-
sult from a private laboratory is received. Because such a
large number of patients seek healthcare in the private
sector in South Asia, it is important that governments
take steps to ensure at least a minimal standard of ser-
vice provision. For private laboratories in particular, it is
very difficult for a patient to distinguish between labora-
tories that provide poor quality versus high quality diag-
nostic services, particularly as it appears that higher cost
is not associated with improved accuracy of results.
Without any regulation and enforcement of standards,
laboratories may have more incentive to cut costs and
compromise on service quality, potentially allowing
them to either competitively lower their prices or in-
crease their profit margins.
It must be acknowledged that this novel method of
assessing AFB smear microscopy quality has a different
purpose and role than traditional EQA methods. Stand-
ard EQA methods allow the assessor to identify the stage
in the sputum smear microscopy process at which an
error is being made. However, in order to conduct the
EQA, the laboratory must agree to be assessed and the
laboratory technicians may be aware of the assessment.
Both of these features of EQA pose major disadvantages
when assessing private laboratories, as in Pakistan and
many other developing country contexts, these facilities
are not bound by law to cooperate with government
EQA programs. Often the laboratories that require the
most training and regulation are those that decline to
participate in EQA, knowing the extra work they may
have to take on as a result of participation. Furthermore,
even when laboratories agree to participate in EQA pro-
grams, the results of their EQA may not be representa-
tive of the quality of their work under normal
conditions.
Using this novel methodology, it is not possible to
identify the reason for the inaccurate sputum smear mi-
croscopy results. The laboratories we assessed may have
provided false negative results due to any of the follow-
ing reasons: incorrect fixing of sputum specimens to
slides, incorrect staining procedures, poor microscopy
techniques, insufficient time spent on reading slides or
even failure to process the specimen at all. However, a
major benefit of this methodology is that it allows the
assessment of any laboratory that accepts specimens
from walk-in patients.
This study and methodology are not without potential
limitations. The number of laboratories included and
specimens sent to them was relatively small, limiting the
ability of these results to be generalized. However, the
largest, most well-known private laboratories in Karachi,
which together with their satellite specimen collection
sites make up the majority of private laboratory services
in the city, were evaluated by this initiative. Further, this
assessment was conducted immediately before a PPM
active-case finding project aimed at improving private
laboratory diagnostic services started activities; a more
comprehensive, baseline study with additional specimens
and varied amounts of bacilli was impossible because
the PPM project conducted site inspections and smear
microscopy training at several of the sites under review.
Despite these limitations, this methodology was able to
identify poor quality smear microscopy services at pri-
vate laboratories that are unwilling to participate in trad-
itional EQA programs.
Mtb has the tendency to clump together in sputum
and it is possible that some labs would select a section
of the Mtb-spiked sputum specimen to read which does
not contain bacteria. To minimize this from occurring,
spiked specimens were created and thoroughly homoge-
nized the morning they were submitted to private la-
boratories. The fact that specimens were sent to the
laboratories over a three day period and that reported
results were either very accurate or very inaccurate, sug-
gests that laboratory procedures, rather than random
clumping of specimens, were responsible for the differ-
ences found.
Conclusions
Despite the small sample size of this study, its findings
are both interesting and troubling. The size of the pri-
vate healthcare sector in South Asia makes it an essen-
tial partner for TB care, yet many of its institutions offer
substandard care. Continued engagement, capacity
building and rigorous monitoring of standards at private
laboratories are of vital importance for the control of
TB. Though our findings are specific for TB diagnostic
tests, they could be symptomatic of other tests
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performed in private laboratories and warrant further
investigation.
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